FindTrial
Sign In

Examining the effectiveness of two different doses of dexamethasone when used as an additive to upper limb nerve block

Dose response of dexamethasone as an adjuvant for supraclavicular brachial plexus block - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064718
Enrollment
60
Registered
2024-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S698- Other specified injuries of wrist,hand and finger(s) Health Condition 2: S599- Unspecified injury of elbow and forearm Health Condition 3: S499- Unspecified injury of shoulder andupper arm

Interventions

Control Intervention1: Dexamethasone 2mg: Documenting dose response when dexamethasone 2mg is used as additive to supraclavicular brachial plexus block. Control Intervention2: Dexamethasone 4mg: Docum

Sponsors

Divya Prabhash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing upper limb surgeries under supraclavicular brachial plexus block.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Neurological deficits involving brachial plexus 3. Patients with diabetes mellitus, hepatic or renal failure

Design outcomes

Primary

MeasureTime frame
To determine onset of sensory blockade with two different doses of dexamethasone as adjuvant to block.Timepoint: In minutes—

Secondary

MeasureTime frame
Onset and Duration of motor blockadeTimepoint: In minutes;Side Effects / ComplicationsTimepoint: (If any);To determine duration of sensory blockade with two different doses of dexamethasone as adjuvant to block.Timepoint: In minutes—

Countries

India

Contacts

Public ContactDivya Prabhash

Kasturba Medical College Hospital Manipal

rajaramprabhu007@gmail.com9845835499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026